^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             37    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991002    
                           13991004 13991007 13991009    
                           13991010 16591001 16591003    
                           16591006 17601002 17601003    
                           17601005 17601007 17601012    
                           17601014 17601025 17661002    
                           17661004 17661006 19691001    
                           19731001 19731004 19731006    
                           19831001 19831005 19831008    
                           19901003                      
      AVISITN         4    1 4 8 12                      
      SSNRISN         2    1 2                           
      trtn            3    1 2 3                         
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Covariance Parameters            10
              Columns in X                     35
              Columns in Z                      0
              Subjects                         37
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read             121
          Number of Observations Used             121
          Number of Observations Not Used           0


 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       337.49913210                
          1              2       304.20937133      0.02841894
          2              1       302.17328817      0.00539172
          3              1       301.81542447      0.00036696
          4              1       301.79296860      0.00000275
          5              1       301.79280794      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.8044
                UN(2,1)     id           0.3079
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(2,2)     id           0.8470
                UN(3,1)     id           0.3121
                UN(3,2)     id           0.4387
                UN(3,3)     id           1.2006
                UN(4,1)     id           0.4113
                UN(4,2)     id           0.6957
                UN(4,3)     id           0.9412
                UN(4,4)     id           1.5411


                        Fit Statistics

             -2 Res Log Likelihood           301.8
             AIC (Smaller is Better)         321.8
             AICC (Smaller is Better)        324.2
             BIC (Smaller is Better)         337.9
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         35.71          <.0001


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1    33.5       9.43    0.0042
      trtn                  2    32.2       0.00    0.9982
      AVISITN               3    24.5       0.94    0.4387
      AVISITN*trtn          6    28.2       1.44    0.2337
      BASE*AVISITN          3    24.2       1.15    0.3486
      SSNRISN               1    31.8       0.23    0.6380
      AVISITN*SSNRISN       3    25.5       2.33    0.0983
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                Analysis                       Standard
 Effect         Visit (N)    trtn   Estimate      Error     DF

 AVISITN*trtn            1   1       -0.8618     0.3231     32
 AVISITN*trtn            1   2       -0.2831     0.2820     32
 AVISITN*trtn            1   3       -0.1500     0.3167     32
 AVISITN*trtn            4   1       -0.8709     0.3323   26.6
 AVISITN*trtn            4   2       -1.0914     0.2982   27.2
 AVISITN*trtn            4   3       -1.4831     0.3726   27.7
 AVISITN*trtn            8   1       -1.2613     0.4149   26.5
 AVISITN*trtn            8   2       -1.2586     0.3974     29
 AVISITN*trtn            8   3       -1.3761     0.4724   27.6
 AVISITN*trtn           12   1       -1.2495     0.5098   27.6
 AVISITN*trtn           12   2       -1.5618     0.4385     27
 AVISITN*trtn           12   3       -1.1365     0.5603   27.6

 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                Analysis
 Effect         Visit (N)    trtn   t Value   Pr > |t|    Alpha

 AVISITN*trtn            1   1        -2.67     0.0119     0.05
 AVISITN*trtn            1   2        -1.00     0.3231     0.05
 AVISITN*trtn            1   3        -0.47     0.6391     0.05
 AVISITN*trtn            4   1        -2.62     0.0143     0.05
 AVISITN*trtn            4   2        -3.66     0.0011     0.05
 AVISITN*trtn            4   3        -3.98     0.0005     0.05
 AVISITN*trtn            8   1        -3.04     0.0053     0.05
 AVISITN*trtn            8   2        -3.17     0.0036     0.05
 AVISITN*trtn            8   3        -2.91     0.0070     0.05
 AVISITN*trtn           12   1        -2.45     0.0208     0.05
 AVISITN*trtn           12   2        -3.56     0.0014     0.05
 AVISITN*trtn           12   3        -2.03     0.0523     0.05

 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                   Analysis
    Effect         Visit (N)    trtn      Lower       Upper

    AVISITN*trtn            1   1       -1.5199     -0.2036
    AVISITN*trtn            1   2       -0.8576      0.2914
    AVISITN*trtn            1   3       -0.7951      0.4951
    AVISITN*trtn            4   1       -1.5532     -0.1886
    AVISITN*trtn            4   2       -1.7030     -0.4797
    AVISITN*trtn            4   3       -2.2468     -0.7193
    AVISITN*trtn            8   1       -2.1133     -0.4092
    AVISITN*trtn            8   2       -2.0714     -0.4458
    AVISITN*trtn            8   3       -2.3444     -0.4078
    AVISITN*trtn           12   1       -2.2943     -0.2046
    AVISITN*trtn           12   2       -2.4613     -0.6622
    AVISITN*trtn           12   3       -2.2850     0.01201
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           1  1              1  2       -0.5787
  AVISITN*trtn           1  1              1  3       -0.7118
  AVISITN*trtn           1  1              4  1      0.009085
  AVISITN*trtn           1  1              4  2        0.2296
  AVISITN*trtn           1  1              4  3        0.6213
  AVISITN*trtn           1  1              8  1        0.3995
  AVISITN*trtn           1  1              8  2        0.3968
  AVISITN*trtn           1  1              8  3        0.5143
  AVISITN*trtn           1  1             12  1        0.3877
  AVISITN*trtn           1  1             12  2        0.7000
  AVISITN*trtn           1  1             12  3        0.2747
  AVISITN*trtn           1  2              1  3       -0.1331
  AVISITN*trtn           1  2              4  1        0.5878
  AVISITN*trtn           1  2              4  2        0.8083
  AVISITN*trtn           1  2              4  3        1.2000
  AVISITN*trtn           1  2              8  1        0.9782
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           1  1              1  2        0.3816
  AVISITN*trtn           1  1              1  3        0.4026
  AVISITN*trtn           1  1              4  1        0.3673
  AVISITN*trtn           1  1              4  2        0.4227
  AVISITN*trtn           1  1              4  3        0.4764
  AVISITN*trtn           1  1              8  1        0.4422
  AVISITN*trtn           1  1              8  2        0.4975
  AVISITN*trtn           1  1              8  3        0.5577
  AVISITN*trtn           1  1             12  1        0.5074
  AVISITN*trtn           1  1             12  2        0.5263
  AVISITN*trtn           1  1             12  3        0.6297
  AVISITN*trtn           1  2              1  3        0.3443
  AVISITN*trtn           1  2              4  1        0.4187
  AVISITN*trtn           1  2              4  2        0.3280
  AVISITN*trtn           1  2              4  3        0.4415
  AVISITN*trtn           1  2              8  1        0.4866
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           1  1              1  2        32    -1.52
AVISITN*trtn           1  1              1  3        32    -1.77
AVISITN*trtn           1  1              4  1      28.9     0.02
AVISITN*trtn           1  1              4  2      57.2     0.54
AVISITN*trtn           1  1              4  3      54.6     1.30
AVISITN*trtn           1  1              8  1      23.3     0.90
AVISITN*trtn           1  1              8  2      55.2     0.80
AVISITN*trtn           1  1              8  3      47.5     0.92
AVISITN*trtn           1  1             12  1      25.9     0.76
AVISITN*trtn           1  1             12  2      49.2     1.33
AVISITN*trtn           1  1             12  3      42.6     0.44
AVISITN*trtn           1  2              1  3        32    -0.39
AVISITN*trtn           1  2              4  1        53     1.40
AVISITN*trtn           1  2              4  2      29.6     2.46
AVISITN*trtn           1  2              4  3      50.5     2.72
AVISITN*trtn           1  2              8  1      45.7     2.01
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           1  1              1  2        0.1392
  AVISITN*trtn           1  1              1  3        0.0866
  AVISITN*trtn           1  1              4  1        0.9804
  AVISITN*trtn           1  1              4  2        0.5891
  AVISITN*trtn           1  1              4  3        0.1976
  AVISITN*trtn           1  1              8  1        0.3755
  AVISITN*trtn           1  1              8  2        0.4285
  AVISITN*trtn           1  1              8  3        0.3611
  AVISITN*trtn           1  1             12  1        0.4518
  AVISITN*trtn           1  1             12  2        0.1897
  AVISITN*trtn           1  1             12  3        0.6648
  AVISITN*trtn           1  2              1  3        0.7016
  AVISITN*trtn           1  2              4  1        0.1662
  AVISITN*trtn           1  2              4  2        0.0198
  AVISITN*trtn           1  2              4  3        0.0090
  AVISITN*trtn           1  2              8  1        0.0503
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           1  1              1  2        0.05
   AVISITN*trtn           1  1              1  3        0.05
   AVISITN*trtn           1  1              4  1        0.05
   AVISITN*trtn           1  1              4  2        0.05
   AVISITN*trtn           1  1              4  3        0.05
   AVISITN*trtn           1  1              8  1        0.05
   AVISITN*trtn           1  1              8  2        0.05
   AVISITN*trtn           1  1              8  3        0.05
   AVISITN*trtn           1  1             12  1        0.05
   AVISITN*trtn           1  1             12  2        0.05
   AVISITN*trtn           1  1             12  3        0.05
   AVISITN*trtn           1  2              1  3        0.05
   AVISITN*trtn           1  2              4  1        0.05
   AVISITN*trtn           1  2              4  2        0.05
   AVISITN*trtn           1  2              4  3        0.05
   AVISITN*trtn           1  2              8  1        0.05
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           1  1              1  2       -1.3559
  AVISITN*trtn           1  1              1  3       -1.5318
  AVISITN*trtn           1  1              4  1       -0.7422
  AVISITN*trtn           1  1              4  2       -0.6167
  AVISITN*trtn           1  1              4  3       -0.3336
  AVISITN*trtn           1  1              8  1       -0.5145
  AVISITN*trtn           1  1              8  2       -0.6001
  AVISITN*trtn           1  1              8  3       -0.6073
  AVISITN*trtn           1  1             12  1       -0.6555
  AVISITN*trtn           1  1             12  2       -0.3576
  AVISITN*trtn           1  1             12  3       -0.9955
  AVISITN*trtn           1  2              1  3       -0.8345
  AVISITN*trtn           1  2              4  1       -0.2520
  AVISITN*trtn           1  2              4  2        0.1381
  AVISITN*trtn           1  2              4  3        0.3134
  AVISITN*trtn           1  2              8  1      -0.00142
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           1  1              1  2        0.1985
  AVISITN*trtn           1  1              1  3        0.1082
  AVISITN*trtn           1  1              4  1        0.7604
  AVISITN*trtn           1  1              4  2        1.0759
  AVISITN*trtn           1  1              4  3        1.5761
  AVISITN*trtn           1  1              8  1        1.3135
  AVISITN*trtn           1  1              8  2        1.3937
  AVISITN*trtn           1  1              8  3        1.6359
  AVISITN*trtn           1  1             12  1        1.4308
  AVISITN*trtn           1  1             12  2        1.7576
  AVISITN*trtn           1  1             12  3        1.5449
  AVISITN*trtn           1  2              1  3        0.5683
  AVISITN*trtn           1  2              4  1        1.4276
  AVISITN*trtn           1  2              4  2        1.4785
  AVISITN*trtn           1  2              4  3        2.0866
  AVISITN*trtn           1  2              8  1        1.9578
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           1  2              8  2        0.9755
  AVISITN*trtn           1  2              8  3        1.0930
  AVISITN*trtn           1  2             12  1        0.9664
  AVISITN*trtn           1  2             12  2        1.2787
  AVISITN*trtn           1  2             12  3        0.8534
  AVISITN*trtn           1  3              4  1        0.7209
  AVISITN*trtn           1  3              4  2        0.9414
  AVISITN*trtn           1  3              4  3        1.3331
  AVISITN*trtn           1  3              8  1        1.1113
  AVISITN*trtn           1  3              8  2        1.1086
  AVISITN*trtn           1  3              8  3        1.2261
  AVISITN*trtn           1  3             12  1        1.0995
  AVISITN*trtn           1  3             12  2        1.4118
  AVISITN*trtn           1  3             12  3        0.9865
  AVISITN*trtn           4  1              4  2        0.2205
  AVISITN*trtn           4  1              4  3        0.6122
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           1  2              8  2        0.4193
  AVISITN*trtn           1  2              8  3        0.5281
  AVISITN*trtn           1  2             12  1        0.5655
  AVISITN*trtn           1  2             12  2        0.4364
  AVISITN*trtn           1  2             12  3        0.6018
  AVISITN*trtn           1  3              4  1        0.4409
  AVISITN*trtn           1  3              4  2        0.4072
  AVISITN*trtn           1  3              4  3        0.4030
  AVISITN*trtn           1  3              8  1        0.5058
  AVISITN*trtn           1  3              8  2        0.4842
  AVISITN*trtn           1  3              8  3        0.4956
  AVISITN*trtn           1  3             12  1        0.5817
  AVISITN*trtn           1  3             12  2        0.5111
  AVISITN*trtn           1  3             12  3        0.5583
  AVISITN*trtn           4  1              4  2        0.4005
  AVISITN*trtn           4  1              4  3        0.4591
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           1  2              8  2      26.3     2.33
AVISITN*trtn           1  2              8  3      41.7     2.07
AVISITN*trtn           1  2             12  1      41.8     1.71
AVISITN*trtn           1  2             12  2      25.3     2.93
AVISITN*trtn           1  2             12  3      37.9     1.42
AVISITN*trtn           1  3              4  1      55.5     1.63
AVISITN*trtn           1  3              4  2      58.2     2.31
AVISITN*trtn           1  3              4  3        31     3.31
AVISITN*trtn           1  3              8  1      49.3     2.20
AVISITN*trtn           1  3              8  2      53.1     2.29
AVISITN*trtn           1  3              8  3      25.5     2.47
AVISITN*trtn           1  3             12  1        45     1.89
AVISITN*trtn           1  3             12  2      47.7     2.76
AVISITN*trtn           1  3             12  3      26.1     1.77
AVISITN*trtn           4  1              4  2        27     0.55
AVISITN*trtn           4  1              4  3      27.5     1.33
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           1  2              8  2        0.0279
  AVISITN*trtn           1  2              8  3        0.0447
  AVISITN*trtn           1  2             12  1        0.0949
  AVISITN*trtn           1  2             12  2        0.0071
  AVISITN*trtn           1  2             12  3        0.1643
  AVISITN*trtn           1  3              4  1        0.1077
  AVISITN*trtn           1  3              4  2        0.0243
  AVISITN*trtn           1  3              4  3        0.0024
  AVISITN*trtn           1  3              8  1        0.0328
  AVISITN*trtn           1  3              8  2        0.0261
  AVISITN*trtn           1  3              8  3        0.0203
  AVISITN*trtn           1  3             12  1        0.0652
  AVISITN*trtn           1  3             12  2        0.0081
  AVISITN*trtn           1  3             12  3        0.0889
  AVISITN*trtn           4  1              4  2        0.5864
  AVISITN*trtn           4  1              4  3        0.1933
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           1  2              8  2        0.05
   AVISITN*trtn           1  2              8  3        0.05
   AVISITN*trtn           1  2             12  1        0.05
   AVISITN*trtn           1  2             12  2        0.05
   AVISITN*trtn           1  2             12  3        0.05
   AVISITN*trtn           1  3              4  1        0.05
   AVISITN*trtn           1  3              4  2        0.05
   AVISITN*trtn           1  3              4  3        0.05
   AVISITN*trtn           1  3              8  1        0.05
   AVISITN*trtn           1  3              8  2        0.05
   AVISITN*trtn           1  3              8  3        0.05
   AVISITN*trtn           1  3             12  1        0.05
   AVISITN*trtn           1  3             12  2        0.05
   AVISITN*trtn           1  3             12  3        0.05
   AVISITN*trtn           4  1              4  2        0.05
   AVISITN*trtn           4  1              4  3        0.05
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           1  2              8  2        0.1142
  AVISITN*trtn           1  2              8  3       0.02701
  AVISITN*trtn           1  2             12  1       -0.1750
  AVISITN*trtn           1  2             12  2        0.3805
  AVISITN*trtn           1  2             12  3       -0.3649
  AVISITN*trtn           1  3              4  1       -0.1626
  AVISITN*trtn           1  3              4  2        0.1265
  AVISITN*trtn           1  3              4  3        0.5113
  AVISITN*trtn           1  3              8  1       0.09492
  AVISITN*trtn           1  3              8  2        0.1374
  AVISITN*trtn           1  3              8  3        0.2065
  AVISITN*trtn           1  3             12  1      -0.07204
  AVISITN*trtn           1  3             12  2        0.3840
  AVISITN*trtn           1  3             12  3       -0.1608
  AVISITN*trtn           4  1              4  2       -0.6012
  AVISITN*trtn           4  1              4  3       -0.3290
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           1  2              8  2        1.8368
  AVISITN*trtn           1  2              8  3        2.1591
  AVISITN*trtn           1  2             12  1        2.1078
  AVISITN*trtn           1  2             12  2        2.1769
  AVISITN*trtn           1  2             12  3        2.0717
  AVISITN*trtn           1  3              4  1        1.6044
  AVISITN*trtn           1  3              4  2        1.7564
  AVISITN*trtn           1  3              4  3        2.1549
  AVISITN*trtn           1  3              8  1        2.1277
  AVISITN*trtn           1  3              8  2        2.0798
  AVISITN*trtn           1  3              8  3        2.2458
  AVISITN*trtn           1  3             12  1        2.2710
  AVISITN*trtn           1  3             12  2        2.4396
  AVISITN*trtn           1  3             12  3        2.1339
  AVISITN*trtn           4  1              4  2        1.0422
  AVISITN*trtn           4  1              4  3        1.5534
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           4  1              8  1        0.3904
  AVISITN*trtn           4  1              8  2        0.3877
  AVISITN*trtn           4  1              8  3        0.5052
  AVISITN*trtn           4  1             12  1        0.3786
  AVISITN*trtn           4  1             12  2        0.6909
  AVISITN*trtn           4  1             12  3        0.2656
  AVISITN*trtn           4  2              4  3        0.3917
  AVISITN*trtn           4  2              8  1        0.1699
  AVISITN*trtn           4  2              8  2        0.1672
  AVISITN*trtn           4  2              8  3        0.2847
  AVISITN*trtn           4  2             12  1        0.1581
  AVISITN*trtn           4  2             12  2        0.4704
  AVISITN*trtn           4  2             12  3       0.04514
  AVISITN*trtn           4  3              8  1       -0.2218
  AVISITN*trtn           4  3              8  2       -0.2245
  AVISITN*trtn           4  3              8  3       -0.1070
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           4  1              8  1        0.4102
  AVISITN*trtn           4  1              8  2        0.4979
  AVISITN*trtn           4  1              8  3        0.5597
  AVISITN*trtn           4  1             12  1        0.4348
  AVISITN*trtn           4  1             12  2        0.5197
  AVISITN*trtn           4  1             12  3        0.6265
  AVISITN*trtn           4  2              4  3        0.4102
  AVISITN*trtn           4  2              8  1        0.4907
  AVISITN*trtn           4  2              8  2        0.3973
  AVISITN*trtn           4  2              8  3        0.5286
  AVISITN*trtn           4  2             12  1        0.5618
  AVISITN*trtn           4  2             12  2        0.3750
  AVISITN*trtn           4  2             12  3        0.5914
  AVISITN*trtn           4  3              8  1        0.5390
  AVISITN*trtn           4  3              8  2        0.5140
  AVISITN*trtn           4  3              8  3        0.4738
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           4  1              8  1        24     0.95
AVISITN*trtn           4  1              8  2      52.2     0.78
AVISITN*trtn           4  1              8  3      46.8     0.90
AVISITN*trtn           4  1             12  1      21.6     0.87
AVISITN*trtn           4  1             12  2      43.8     1.33
AVISITN*trtn           4  1             12  3      39.9     0.42
AVISITN*trtn           4  2              4  3      28.1     0.95
AVISITN*trtn           4  2              8  1      45.9     0.35
AVISITN*trtn           4  2              8  2      27.1     0.42
AVISITN*trtn           4  2              8  3        45     0.54
AVISITN*trtn           4  2             12  1      39.7     0.28
AVISITN*trtn           4  2             12  2      22.1     1.25
AVISITN*trtn           4  2             12  3      38.2     0.08
AVISITN*trtn           4  3              8  1      50.1    -0.41
AVISITN*trtn           4  3              8  2      55.2    -0.44
AVISITN*trtn           4  3              8  3        25    -0.23
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           4  1              8  1        0.3507
  AVISITN*trtn           4  1              8  2        0.4397
  AVISITN*trtn           4  1              8  3        0.3713
  AVISITN*trtn           4  1             12  1        0.3935
  AVISITN*trtn           4  1             12  2        0.1906
  AVISITN*trtn           4  1             12  3        0.6738
  AVISITN*trtn           4  2              4  3        0.3478
  AVISITN*trtn           4  2              8  1        0.7307
  AVISITN*trtn           4  2              8  2        0.6772
  AVISITN*trtn           4  2              8  3        0.5928
  AVISITN*trtn           4  2             12  1        0.7799
  AVISITN*trtn           4  2             12  2        0.2228
  AVISITN*trtn           4  2             12  3        0.9396
  AVISITN*trtn           4  3              8  1        0.6825
  AVISITN*trtn           4  3              8  2        0.6640
  AVISITN*trtn           4  3              8  3        0.8232
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           4  1              8  1        0.05
   AVISITN*trtn           4  1              8  2        0.05
   AVISITN*trtn           4  1              8  3        0.05
   AVISITN*trtn           4  1             12  1        0.05
   AVISITN*trtn           4  1             12  2        0.05
   AVISITN*trtn           4  1             12  3        0.05
   AVISITN*trtn           4  2              4  3        0.05
   AVISITN*trtn           4  2              8  1        0.05
   AVISITN*trtn           4  2              8  2        0.05
   AVISITN*trtn           4  2              8  3        0.05
   AVISITN*trtn           4  2             12  1        0.05
   AVISITN*trtn           4  2             12  2        0.05
   AVISITN*trtn           4  2             12  3        0.05
   AVISITN*trtn           4  3              8  1        0.05
   AVISITN*trtn           4  3              8  2        0.05
   AVISITN*trtn           4  3              8  3        0.05
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           4  1              8  1       -0.4561
  AVISITN*trtn           4  1              8  2       -0.6113
  AVISITN*trtn           4  1              8  3       -0.6209
  AVISITN*trtn           4  1             12  1       -0.5240
  AVISITN*trtn           4  1             12  2       -0.3567
  AVISITN*trtn           4  1             12  3       -1.0007
  AVISITN*trtn           4  2              4  3       -0.4485
  AVISITN*trtn           4  2              8  1       -0.8179
  AVISITN*trtn           4  2              8  2       -0.6479
  AVISITN*trtn           4  2              8  3       -0.7799
  AVISITN*trtn           4  2             12  1       -0.9776
  AVISITN*trtn           4  2             12  2       -0.3072
  AVISITN*trtn           4  2             12  3       -1.1520
  AVISITN*trtn           4  3              8  1       -1.3043
  AVISITN*trtn           4  3              8  2       -1.2544
  AVISITN*trtn           4  3              8  3       -1.0827
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           4  1              8  1        1.2369
  AVISITN*trtn           4  1              8  2        1.3867
  AVISITN*trtn           4  1              8  3        1.6313
  AVISITN*trtn           4  1             12  1        1.2812
  AVISITN*trtn           4  1             12  2        1.7385
  AVISITN*trtn           4  1             12  3        1.5319
  AVISITN*trtn           4  2              4  3        1.2319
  AVISITN*trtn           4  2              8  1        1.1577
  AVISITN*trtn           4  2              8  2        0.9823
  AVISITN*trtn           4  2              8  3        1.3494
  AVISITN*trtn           4  2             12  1        1.2937
  AVISITN*trtn           4  2             12  2        1.2479
  AVISITN*trtn           4  2             12  3        1.2422
  AVISITN*trtn           4  3              8  1        0.8607
  AVISITN*trtn           4  3              8  2        0.8054
  AVISITN*trtn           4  3              8  3        0.8688
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           4  3             12  1       -0.2336
  AVISITN*trtn           4  3             12  2       0.07870
  AVISITN*trtn           4  3             12  3       -0.3466
  AVISITN*trtn           8  1              8  2      -0.00270
  AVISITN*trtn           8  1              8  3        0.1148
  AVISITN*trtn           8  1             12  1      -0.01182
  AVISITN*trtn           8  1             12  2        0.3005
  AVISITN*trtn           8  1             12  3       -0.1248
  AVISITN*trtn           8  2              8  3        0.1175
  AVISITN*trtn           8  2             12  1      -0.00912
  AVISITN*trtn           8  2             12  2        0.3032
  AVISITN*trtn           8  2             12  3       -0.1221
  AVISITN*trtn           8  3             12  1       -0.1266
  AVISITN*trtn           8  3             12  2        0.1857
  AVISITN*trtn           8  3             12  3       -0.2396
  AVISITN*trtn          12  1             12  2        0.3123
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           4  3             12  1        0.6060
  AVISITN*trtn           4  3             12  2        0.5280
  AVISITN*trtn           4  3             12  3        0.4824
  AVISITN*trtn           8  1              8  2        0.5161
  AVISITN*trtn           8  1              8  3        0.5860
  AVISITN*trtn           8  1             12  1        0.4179
  AVISITN*trtn           8  1             12  2        0.5720
  AVISITN*trtn           8  1             12  3        0.6748
  AVISITN*trtn           8  2              8  3        0.4955
  AVISITN*trtn           8  2             12  1        0.6277
  AVISITN*trtn           8  2             12  2        0.4057
  AVISITN*trtn           8  2             12  3        0.6487
  AVISITN*trtn           8  3             12  1        0.6791
  AVISITN*trtn           8  3             12  2        0.5973
  AVISITN*trtn           8  3             12  3        0.4907
  AVISITN*trtn          12  1             12  2        0.5930
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           4  3             12  1      44.1    -0.39
AVISITN*trtn           4  3             12  2      47.8     0.15
AVISITN*trtn           4  3             12  3      21.9    -0.72
AVISITN*trtn           8  1              8  2      27.5    -0.01
AVISITN*trtn           8  1              8  3        27     0.20
AVISITN*trtn           8  1             12  1        22    -0.03
AVISITN*trtn           8  1             12  2      41.9     0.53
AVISITN*trtn           8  1             12  3      40.3    -0.18
AVISITN*trtn           8  2              8  3      26.3     0.24
AVISITN*trtn           8  2             12  1      42.9    -0.01
AVISITN*trtn           8  2             12  2      25.8     0.75
AVISITN*trtn           8  2             12  3      42.3    -0.19
AVISITN*trtn           8  3             12  1      42.8    -0.19
AVISITN*trtn           8  3             12  2      44.7     0.31
AVISITN*trtn           8  3             12  3      24.1    -0.49
AVISITN*trtn          12  1             12  2      26.9     0.53
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           4  3             12  1        0.7017
  AVISITN*trtn           4  3             12  2        0.8821
  AVISITN*trtn           4  3             12  3        0.4801
  AVISITN*trtn           8  1              8  2        0.9959
  AVISITN*trtn           8  1              8  3        0.8461
  AVISITN*trtn           8  1             12  1        0.9777
  AVISITN*trtn           8  1             12  2        0.6021
  AVISITN*trtn           8  1             12  3        0.8542
  AVISITN*trtn           8  2              8  3        0.8143
  AVISITN*trtn           8  2             12  1        0.9885
  AVISITN*trtn           8  2             12  2        0.4616
  AVISITN*trtn           8  2             12  3        0.8517
  AVISITN*trtn           8  3             12  1        0.8529
  AVISITN*trtn           8  3             12  2        0.7574
  AVISITN*trtn           8  3             12  3        0.6298
  AVISITN*trtn          12  1             12  2        0.6027
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           4  3             12  1        0.05
   AVISITN*trtn           4  3             12  2        0.05
   AVISITN*trtn           4  3             12  3        0.05
   AVISITN*trtn           8  1              8  2        0.05
   AVISITN*trtn           8  1              8  3        0.05
   AVISITN*trtn           8  1             12  1        0.05
   AVISITN*trtn           8  1             12  2        0.05
   AVISITN*trtn           8  1             12  3        0.05
   AVISITN*trtn           8  2              8  3        0.05
   AVISITN*trtn           8  2             12  1        0.05
   AVISITN*trtn           8  2             12  2        0.05
   AVISITN*trtn           8  2             12  3        0.05
   AVISITN*trtn           8  3             12  1        0.05
   AVISITN*trtn           8  3             12  2        0.05
   AVISITN*trtn           8  3             12  3        0.05
   AVISITN*trtn          12  1             12  2        0.05
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           4  3             12  1       -1.4548
  AVISITN*trtn           4  3             12  2       -0.9831
  AVISITN*trtn           4  3             12  3       -1.3472
  AVISITN*trtn           8  1              8  2       -1.0607
  AVISITN*trtn           8  1              8  3       -1.0875
  AVISITN*trtn           8  1             12  1       -0.8783
  AVISITN*trtn           8  1             12  2       -0.8538
  AVISITN*trtn           8  1             12  3       -1.4882
  AVISITN*trtn           8  2              8  3       -0.9003
  AVISITN*trtn           8  2             12  1       -1.2751
  AVISITN*trtn           8  2             12  2       -0.5310
  AVISITN*trtn           8  2             12  3       -1.4310
  AVISITN*trtn           8  3             12  1       -1.4963
  AVISITN*trtn           8  3             12  2       -1.0177
  AVISITN*trtn           8  3             12  3       -1.2523
  AVISITN*trtn          12  1             12  2       -0.9045
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           4  3             12  1        0.9875
  AVISITN*trtn           4  3             12  2        1.1405
  AVISITN*trtn           4  3             12  3        0.6541
  AVISITN*trtn           8  1              8  2        1.0553
  AVISITN*trtn           8  1              8  3        1.3172
  AVISITN*trtn           8  1             12  1        0.8546
  AVISITN*trtn           8  1             12  2        1.4548
  AVISITN*trtn           8  1             12  3        1.2386
  AVISITN*trtn           8  2              8  3        1.1353
  AVISITN*trtn           8  2             12  1        1.2569
  AVISITN*trtn           8  2             12  2        1.1374
  AVISITN*trtn           8  2             12  3        1.1869
  AVISITN*trtn           8  3             12  1        1.2430
  AVISITN*trtn           8  3             12  2        1.3890
  AVISITN*trtn           8  3             12  3        0.7731
  AVISITN*trtn          12  1             12  2        1.5292
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn          12  1             12  3       -0.1129
  AVISITN*trtn          12  2             12  3       -0.4253

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn          12  1             12  3        0.6550
  AVISITN*trtn          12  2             12  3        0.5972

 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn          12  1             12  3      25.8    -0.17
AVISITN*trtn          12  2             12  3      27.1    -0.71

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn          12  1             12  3        0.8644
  AVISITN*trtn          12  2             12  3        0.4825

 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn          12  1             12  3        0.05
   AVISITN*trtn          12  2             12  3        0.05

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn          12  1             12  3       -1.4599
  AVISITN*trtn          12  2             12  3       -1.6503

 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn          12  1             12  3        1.2340
  AVISITN*trtn          12  2             12  3        0.7998
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
